{"id":"W2031912770","doi":"10.3109/10428194.2014.900763","title":"Sunitinib malate in patients with intermediate-2 or high-risk myelodysplastic syndrome or chronic myelomonocytic leukemia","year":2014,"lang":"en","type":"letter","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Chronic myelomonocytic leukemia; Sunitinib malate; Myelodysplastic syndromes; Medicine; Internal medicine; Oncology; Cancer research; Gastroenterology; Sunitinib; Cancer; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002043724,0.0002994207,0.0006056331,0.0003527015,0.00076352,0.0004828939,0.0003659786,0.003303758,0.00302778],"category_scores_gemma":[0.001288266,0.000116097,0.0004374236,0.0003493668,0.0003657124,0.0006631719,0.0002166513,0.002258892,0.001318263],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001131105,"about_ca_system_score_gemma":0.0005594456,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001209077,"about_ca_topic_score_gemma":0.003624383,"domain_scores_codex":[0.9998077,0.00005307973,0.00001818126,0.00002492168,0.0000456724,0.00005051907],"domain_scores_gemma":[0.9997167,0.0001066458,0.00003311531,0.00001049743,0.00002703041,0.0001058948],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002559381,0.0004220923,0.06961848,0.0005805325,0.0002078297,0.3254653,0.0002567933,0.00119166,0.006192328,0.004889555,0.3912152,0.1974009],"study_design_scores_gemma":[0.001270247,0.002136559,0.07257514,0.0006899809,0.0003516403,0.5723306,0.0006626078,0.0051972,0.003101634,0.01532389,0.3262424,0.0001181025],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"editorial","genre_scores_codex":[0.2149263,0.07956634,0.001339517,0.5990991,0.01458951,0.0001394696,0.000591301,0.0003217223,0.08942676],"genre_scores_gemma":[0.8128681,0.02324554,0.001066999,0.1246144,0.02297914,0.00008046714,0.0005361839,0.00003742094,0.01457179],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.003303758,"threshold_uncertainty_score":0.01012892,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01136352221495713,"score_gpt":0.2360573399854289,"score_spread":0.2246938177704717,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}